On August 29, 2017, Québec’s Superior Court has granted authorization (or leave) to pursue a shareholder class action on behalf of primary and secondary market purchasers of securities issued by Valeant Pharmaceuticals International Inc. Please click here for the Press Release. A copy of the judgment can be viewed here.
Deprecated: category_link is deprecated since version 2.5.0! Use term_link instead. in /var/www/wp-includes/functions.php on line 5089